|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Aldose reductase inhibitors:therapeutic implications for diabetic complications显示文摘 | Oates PJ Mylari BL | | 0，，： | 1 |
| 2 | A sorbitol dehy-drogenase inhibitor of exceptional in vivo potency with a longduration of action: l-(i?)-{4-triazin-2-yl)-2jR, 6S-dimethylpiperazm-l-yI] pyrimidin-2-yl} ethanol 显示文摘 | Mylari B L Oates P J Zembrowski W J | 2002 | JMed Chem2002，45，20： | 1 |
| 3 | Aldose reductase inhibitors:Therapoutic implications for diabetic complications显示文摘 | Oates PJ Mylari BL | 1999 | Expert Opin Investig Drugs1999，8，12： | 1 |
| 4 | A novel series of non-carboxylie acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran-2- sulfonyl)-2H-pyridazin-3-one and congeners显示文摘 | Mylari B L Armento S J Beebe D A | 2005 | J Med Chem2005，48，： | 1 |
| 5 | A novel series of non- carboxylic Acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3- methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and congeners显示文摘 | Mylari B L Armento S J Beebe D A | 2005 | J Med Chem2005，48，20： | 1 |
| 6 | Sorbitol dehydrogenase inhibitors (SDIs): a new potent, enantiomeric SDI, 4--piperazine 1 sulfonic acid dimethylamide显示文摘 | MYLARI B L OATES P J BEEBE D A | 2001 | Journal of Medicinal Chem2001，44，17： | 1 |
| 7 | Sorbitol Dehydrogenase Inhibitors(SDIs): A New Potent, Enantiomeric SDI, 4--piperazine-1- sulfonic Acid Dimethylamide 显示文摘 | Banavara L Mylari Peter J Oates David A Beebe | 2001 | Journal of Medicinal Chemistry2001，44，17： | 1 |
| 8 | A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral aetivily in diabetic rat models: 6-(5-ehloro- 3-methylbenzofuran-2-sulfonyl )-2H-pyridazin-3-one and congeners显示文摘 | MYLARI BL ARMENTO J BEEBE DA | 2005 | J Med Chern2005，48，20： | 1 |
| 9 | Aldose reductase inhibitors:Therapeutic implications for diabetic complications显示文摘 | Oates PJ Mylari BL | | 0，，： | 1 |
| 10 | Novel, potent aldose reductase inhibitors : 3,4-dihydro-4-oxo-3- { methyl}-1-phthalazineacetic acid (zopolrestat) and congeners显示文摘 | Mylari B L Larson E R Beyer T A | 1991 | J Med Chem1991，34，1： | 1 |
| 11 | Sorbitol dehydrogenase inhibitors (SDIs): a new potent, enantiomeric SDI, 4--piperazine-1-sulfonic acid dimethyl-amide显示文摘 | Mylari BL Oates PJ Beebe DA | 2001 | J Med Chem2001，44，17： | 1 |
| 12 | A sorbitol dehydrogenase inhibitor of exceptional in vivo potency with a long duration of action: 1-( R )- { 4- triazin-2-yl)-2R, 6 S -dimet hylpiperazin- 1-yl] pyrimidin-2-yl} ethanol显示文摘 | Mylari BL Oates PJ Zembrowski WJ | 2002 | J Med Chem2002，45，20： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员